Evidence map›Paper›PMID 38067157›Full record

ReviewCells2023

Modulating Growth Factor Receptor Signaling to Promote Corneal Epithelial Homeostasis.

Kate E Tarvestad-Laise, Brian P Ceresa

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. A c-Cbl/Cbl-b antagonist inhibits EGFR ubiquitylation and sustains EGFR phosphorylation to enhance corneal re-epithelialization.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. Repair of Corneal Epithelial Defects.Progress in molecular and subcellular biology · 2026
    Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kate E Tarvestad-LaiseDepartment of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40202, USA.
Brian P CeresaDepartment of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40202, USA.
University of Louisville · US

Funding

Chemical Optimization of c-Cbl Antagonists for Corneal Wound HealingR01EY028911 · NEI · UNIVERSITY OF LOUISVILLE · PI CERESA, BRIAN P. · 2019 to 2023
$1.9M
Optimizing c-Met signaling to enhance corneal epithelial homeostasisF31EY034730 · NEI · UNIVERSITY OF LOUISVILLE · PI TARVESTAD LAISE, KATE · 2024 to 2025
$54k
NEI NIH HHS EY028911NEI NIH HHS F31 EY034730NEI NIH HHS R01 EY028911
6 · The paper itself

Abstract

The corneal epithelium is the first anatomical barrier between the environment and the cornea; it is critical for proper light refraction onto the retina and prevents pathogens (e.g., bacteria, viruses) from entering the immune-privileged eye. Trauma to the highly innervated corneal epithelium is extremely painful and if not resolved quickly or properly, can lead to infection and ultimately blindness. The healthy eye produces its own growth factors and is continuously bathed in tear fluid that contains these proteins and other nutrients to maintain the rapid turnover and homeostasis of the ocular surface. In this article, we review the roles of growth factors in corneal epithelial homeostasis and regeneration and some of the limitations to their use therapeutically.

Indexed as

CorneaEpithelium, CornealHomeostasisIntercellular Signaling Peptides and ProteinsReceptors, Growth FactorSignal TransductionIntercellular Signaling Peptides and ProteinsReceptors, Growth Factorc-Metcorneacorneal epitheliumcorneal nervesgrowth factorgrowth factor receptorwound healing

Identifiers

PMID38067157
PMCPMC10706396
OpenAlexW4389137287

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.